SLC30A7 and myeloid sarcoma: Future research should confirm the associations for these genetic patterns in an independent study population (i.e., testing if having ≥1 risk alleles at HLA-DRB1*15:01, SLC30A7-rs56678847, and AC093277.1-rs6880809 is associated with MS risk with a similar magnitude and confidence).